Today: 10 June 2026
Browse Category

NASDAQ:CLRB 5 May 2026

Cellectar Biosciences Stock: $140 Million Deal Puts Iopofosine FDA Filing in Focus

Cellectar Biosciences Stock: $140 Million Deal Puts Iopofosine FDA Filing in Focus

Cellectar Biosciences secured up to $140 million in new financing and reported a 83.6% overall response rate for iopofosine I 131 in a Phase 2b study for Waldenström macroglobulinemia. The company’s cash had fallen to $13.2 million at the end of 2025, raising doubts about its ability to continue. Shares traded heavily, with volume surging to 53.78 million. Cellectar plans a confirmatory trial and possible FDA filing.
5 May 2026
·

Stock Market Today

  • Fastly (FSLY) Valuation Mixed as Shares Drop Despite Strong Gains
    June 10, 2026, 8:01 AM EDT. Fastly (FSLY) stock fell 9.2% last month and 22.5% over three months despite an 82.8% year-to-date share price rise. The recent pullback brings valuation into focus, with conflicting signals. Popular narrative puts Fastly's fair value at $4.97, suggesting the stock is 275% overvalued versus a closing price of $18.63, based on long-term revenue and margin assumptions for its edge computing services. However, an alternative discounted cash flow (DCF) model estimates a fair value of $23.49, implying shares trade 20.7% below intrinsic value. Investors face divergent outlooks amid uncertainty over the pace of AI and edge workload growth and Fastly's ongoing $103.1 million net loss. This valuation gap poses a challenge in assessing whether the recent weakness is a buying opportunity or market caution.

Latest articles

Archer Aviation Stock Falls After ARK Sale as ACHR Bulls Face Fresh eVTOL Test

Archer Aviation Stock Falls After ARK Sale as ACHR Bulls Face Fresh eVTOL Test

10 June 2026
Archer Aviation plunged 7.16% to $5.32 after ARK Invest dumped over 2.2 million shares across three ETFs, intensifying pressure on a stock already sensitive to funding and FAA certification risks; shares traded at $5.19 premarket as investors weighed cash burn, ongoing losses, and the urgent need for operational milestones before capital runs thin.
Tesla Drops Pre-Market as SpaceX IPO Buzz Puts Pressure on Musk Plays

Tesla Drops Pre-Market as SpaceX IPO Buzz Puts Pressure on Musk Plays

10 June 2026
Tesla slid 3% to $396.68 Tuesday and dropped another 1.26% premarket as SpaceX’s record $75 billion IPO, with over $250 billion in demand, gives investors a new Musk-linked bet, raising fears capital will rotate out of Tesla and other high-growth tech stocks just as Tesla’s next phase relies on heavy AI and robotaxi spending.
Coupang (CPNG) Gains Ahead of South Korea Privacy Fine Ruling

Coupang (CPNG) Gains Ahead of South Korea Privacy Fine Ruling

10 June 2026
Coupang shares jumped 4.68% to $15.90 as investors await a South Korean privacy ruling that could fine the company up to 1.36 trillion won over a breach affecting 33 million records; the commission’s decision, expected as soon as Thursday, will determine the true financial impact and next move for the stock.
Apple Shares Slip After WWDC, Siri AI Plans Leave Upgrade Path Unclear

Apple Shares Slip After WWDC, Siri AI Plans Leave Upgrade Path Unclear

10 June 2026
Apple shares fell $11.01 to $290.55 after WWDC as investors reacted to Siri AI’s delayed, English-only beta launch, strict device limits, and lack of immediate iPhone demand boost, with Morgan Stanley warning over 1.3 billion iPhones can’t access advanced features and regional rollout hurdles in the EU and China raising doubts about a global upgrade cycle.
Go toTop